Microbiome modulators for maintaining dermal health in animals
| Identifier | APVV-23-0005 |
|---|---|
| Funding scheme | Slovak research and development agency |
| Principal investigator at UVLF | Wolaschka Tomáš, PharmDr., PhD. |
| Name of the project’s principal investigator | MVDr. Viola Štrompfová, DrSc. |
| Project duration | 01.07.2024 – 30.06.2028 |
The skin - the largest organ of the body - harbors a wide variety of microbes that, together with their genetic
information and host interactions, form the skin microbiome. Many of these microorganisms are harmless and in
some cases even provide vital functions such as protection against invasion by the pathogenic organisms,
modulation of the function of the skin\\\\\\\'s immune system, as well as acceleration of healing and reduction of
inflammation in case of injury. Dysbiosis refers to the lack of balance among microbial communities within certain
areas of the body that may lead to the onset or progression of diseases and is the focus of current scientific
research. The goal is to find innovative methods to maintain the skin\\\\\\\'s microbial homeostasis and to avoid the use
of antimicrobial treatment, which except the eradication of pathogens causing skin disease, also reduces beneficial
part of the microbiome. Therefore, the intention of the project is to find supplementary therapeutic agent to strictly antibacterial agents in the form of an antibiotic-sensitive, safe and effective bacterium selected from the
commensal skin microbiota of healthy animals, which can be applied to skin lesions to promote healing during
dermatological diseases complicated by infection. Such an approach to therapy prevents further spread of resistance to antibiotics and thus the ineffectiveness of drugs due to resistance and helps to eliminate the use of non-ecological drugs.
Partners
- Institute of Animal Physiology of the Slovak Academy of Science (Project coordinator)
Project outputs
STROMPFOVÁ, Viola - ŠTEMPELOVÁ, Lucia - WOLASCHKA, Tomáš. Antibacterial activity of plant-derived compounds and cream formulations against canine skin bacteria. In: Veterinary Research Communications. 2024. ISSN 0165-7380, Vol. 48, no. 3 (2024), p. 1459-1470. (2024: 2 - IF, 65 - H-index, 2.1 - IF 5y, 0.568 - SJR, Q1 - SJR Best Q, Q2 - JCR Best Q, 0.392 - ABDC).
Publication details